ArticleCancers2022
MORPHEUS Phase II-III Study: A Pre-Planned Interim Safety Analysis and Preliminary Results.
Aurelie Garant et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled ittrialcites it
ArticleCancers2022
Aurelie Garant et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.